Protagenic Therapeutics (PTIX)
NASDAQ:PTIX
Holding PTIX?
Track your performance easily

Protagenic Therapeutics (PTIX) Financial Statements

27 Followers

Protagenic Therapeutics Financial Overview

Protagenic Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.455; its P/E ratio is -0.48; Protagenic Therapeutics is scheduled to report earnings on April 1, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -1.61M$ 1.75M$ -1.66M$ -1.36M$ -1.18M
EBITDA$ -1.59M$ 1.76M$ -1.63M$ -1.34M$ -1.15M
Net Income Common Stockholders$ -1.61M$ -1.72M$ -1.68M$ -1.40M$ -1.21M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 924.60K$ 2.42M$ 4.06M$ 5.27M$ 6.04M
Total Assets$ 1.47M$ 2.58M$ 4.32M$ 5.43M$ 6.92M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -924.60K$ -2.42M$ -4.06M$ -5.27M$ -6.04M
Total Liabilities$ 674.56K$ 446.10K$ 655.25K$ 1.28M$ 1.51M
Stockholders Equity$ 792.52K$ 2.13M$ 3.67M$ 4.15M$ 5.41M
Cash Flow-
Free Cash Flow$ -1.55M$ -1.66M$ -1.24M$ -711.57K$ -1.53M
Operating Cash Flow$ -1.55M$ -1.66M$ -1.14M$ -655.77K$ -1.53M
Investing Cash Flow$ 1.60M$ 1.20M$ 2.28M$ 590.72K$ 1.61M
Financing Cash Flow$ 44.53K----
Currency in USD

Protagenic Therapeutics Earnings and Revenue History

Protagenic Therapeutics Debt to Assets

Protagenic Therapeutics Cash Flow

Protagenic Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis